Bain Capital Life Sciences Investors, LLC Q3 2024 Filing
Filed November 14, 2024
Portfolio Value
$961.2T
Holdings
24
Report Date
Q3 2024
Filing Type
13F-HR
All Holdings (24 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NUVLNUVALENT INC | 2,697,267 | $275.9T | 28.71% | |
| 2 | NAMSNEWAMSTERDAM PHARMA COMPANY | 10,473,913 | $173.9T | 18.09% | |
| 3 | IRONDISC MEDICINE INC | 1,795,735 | $88.2T | 9.18% | |
| 4 | DNTHDIANTHUS THERAPEUTICS INC | 3,013,423 | $82.5T | 8.58% | |
| 5 | YB4PSAVARA INC | 14,565,457 | $61.8T | 6.43% | |
| 6 | PHVSPHARVARIS N V | 3,303,381 | $61.2T | 6.36% | |
| 7 | ANNXANNEXON INC | 8,449,748 | $50.0T | 5.20% | |
| 8 | SLDBSOLID BIOSCIENCES INC | 4,034,582 | $28.1T | 2.93% | |
| 9 | TNGXTANGO THERAPEUTICS INC | 2,712,008 | $20.9T | 2.17% | |
| 10 | KYTXKYVERNA THERAPEUTICS INC | 3,368,370 | $16.5T | 1.71% | |
| 11 | —MERSANA THERAPEUTICS INC | 8,663,673 | $16.4T | 1.70% | |
| 12 | CABACABALETTA BIO INC | 2,760,888 | $13.0T | 1.36% | |
| 13 | ASNSUSDX4 PHARMACEUTICALS INC | 16,915,784 | $11.3T | 1.18% | |
| 14 | IPSCCENTURY THERAPEUTICS INC | 5,410,361 | $9.3T | 0.96% | |
| 15 | AVIRATEA PHARMACEUTICALS INC | 2,485,638 | $8.3T | 0.87% | |
| 16 | CDTXCIDARA THERAPEUTICS INC | 703,080 | $7.6T | 0.79% | |
| 17 | RPIDRAPID MICRO BIOSYSTEMS INC | 8,434,560 | $7.5T | 0.78% | |
| 18 | CCCCC4 THERAPEUTICS INC | 1,111,910 | $6.3T | 0.66% | |
| 19 | SYRSSYROS PHARMACEUTICALS INC | 2,750,151 | $5.9T | 0.62% | |
| 20 | NAUTNAUTILUS BIOTECHNOLOGY INC | 2,000,000 | $5.7T | 0.59% | |
| 21 | MRNS*MARINUS PHARMACEUTICALS INC | 2,693,380 | $4.7T | 0.49% | |
| 22 | XLOXILIO THERAPEUTICS INC | 4,566,817 | $3.6T | 0.37% | |
| 23 | IVVDINVIVYD INC | 1,799,595 | $1.8T | 0.19% | |
| 24 | NAMSNEWAMSTERDAM PHARMA COMPANY | 100,000 | $700.0B | 0.07% |